Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Li, He ^a   Wang, Juan ^a   Xu, Huiyu ^a   Xing, Rui ^a   Pan, Yuanming ^a   Li, Wenmei ^a   Cui, Jiantao ^a   Zhang, Hongbing ^b   Lu, Youyong ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cell growth; FBP2; Gastric cancer; Glycolysis; Prognosis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; FRUCTOSE 1,6 BISPHOSPHATASE 2; FRUCTOSE BISPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HYDROLYSIS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; FEMALE; FRUCTOSE-BISPHOSPHATASE; GENE EXPRESSION; GLYCOLYSIS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84884525258     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-110     Document Type: Article

References (31)

1. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002, 5:5-11. 10.1007/s10120-002-0203-6, 12772880.
2. Milne AN, Carneiro F, O'Morain C, Offerhaus GJA. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet 2009, 126:615-628. 10.1007/s00439-009-0722-x, 2771140, 19657673.
3. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004, 7:61-77.
4. Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006, 208:233-248. 10.1002/path.1868, 16362989.
5. Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutr Metab 2010, 7:7.
6. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Gene Dev 2009, 23:537-548. 10.1101/gad.1756509, 2763495, 19270154.
7. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008, 18:54-61. 10.1016/j.gde.2008.02.003, 2476215, 18387799.
8. Warburg O. Über den stoffwechsel der carcinomzelle. Naturwissenschaften 1924, 12:1131-1137.
9. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314. 10.1126/science.123.3191.309, 13298683.
10. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482. 10.1016/j.ccr.2008.05.005, 18538731.
11. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033. 10.1126/science.1160809, 2849637, 19460998.
12. Chen M, Zhang J, Li N, Qian Z, Zhu M, Li Q, Zheng J, Wang X, Shi G. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One 2011, 6:e25564. 10.1371/journal.pone.0025564, 3198434, 22039417.
13. Liu X, Wang X, Zhang J, Lam EKY, Shin VY, Cheng ASL, Yu J, Chan FKL, Sung JJY, Jin HC. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 2009, 29:442-450.
14. Dzugaj A. Localization and regulation of muscle fructose-1,6-bisphosphatase, the key enzyme of glyconeogenesis. Adv Enzyme Regul 2006, 46:51-71. 10.1016/j.advenzreg.2006.01.021, 16857246.
15. Zang S, Guo R, Zhang L, Lu Y. Integration of statistical inference methods and a novel control measure to improve sensitivity and specificity of data analysis in expression profiling studies. J Biomed Inform 2007, 40:552-560. 10.1016/j.jbi.2007.01.002, 17317331.
16. Hardie DG. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 2004, 117:5479-5487. 10.1242/jcs.01540, 15509864.
17. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997, 11:388-395.
18. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Bio Med 2010, 48:749-762.
19. Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995, 184:39-51. 10.1016/0022-1759(95)00072-I, 7622868.
20. Berg JM, Tymoczko JL, Stryer L. Biochemistry 2007, New York: W. H. Freeman, 6.
21. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20. 10.1016/j.cmet.2007.10.002, 18177721.
22. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell 2007, 12:487-502. 10.1016/j.devcel.2007.03.020, 17419990.
23. Hay N, Sonenberg N. Upstream and downstream of mTOR. Gene Dev 2004, 18:1926-1945. 10.1101/gad.1212704, 15314020.
24. Priebe A, Tan L, Wahl H, Kueck A, He G, Kwok R, Opipari A, Liu JR. Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells. Gynecol Oncol 2011, 122:389-395. 10.1016/j.ygyno.2011.04.024, 21570709.
25. Rattan R, Giri S, Singh AK, Singh I. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 2005, 280:39582-39593. 10.1074/jbc.M507443200, 16176927.
26. Kim D, Chung J. Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol 2002, 35:106-115. 10.5483/BMBRep.2002.35.1.106, 16248975.
27. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
28. Esteller M. Cancer, epigenetics and the Nobel Prizes. Mol Oncol 2012, 6:565-566. 10.1016/j.molonc.2012.10.004, 23141798.
29. Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA methylation and microRNA dysregulation in cancer. Mol Oncol 2012, 6:567-578. 10.1016/j.molonc.2012.07.007, 22902148.
30. Wang X, Jin H. The epigenetic basis of the Warburg effect. Epigenetics 2010, 5:566-568. 10.4161/epi.5.7.12662, 20622527.
31. Bigl M, Jandrig B, Horn L-C, Eschrich K. Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer. Biochem Bioph Res Co 2008, 377:720-724.